Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis
Description
OBJECTIVE: To determine the impact of the COVID-19 pandemic on antimicrobial consumption and trends of therapeutic drugs for COVID-19 treatments, including corticosteroids, remdesivir and monoclonal antibodies (tocilizumab) from April 2017 to
